OxyContin maker will stop promoting opioids to doctors in the U.S.Over the weekend, Purdue said it eliminated more than half its sales staff this week and will no longer send sales representatives to doctors' offices to discuss opioid drugs Dupixent for moderate-to-severe atopic dermatitis in adultsThe drug is the first biologic therapy for eczema to be approved in Canada Baloney Meter: Is advocating against abortion out of line with the charter? Does early exposure to cow’s milk increase type 1 diabetes risk? Despite conflicting research, longterm study results reveal no link Bitcoin: Does it belong in your investment portfolio? Fentanyl increasingly found in drugs in Vancouver's Downtown Eastside: study New report on Canadian cancer care outlines what's missing from the patient experience How do we address Canada’s scarcity of doctors? Does 'ghosting' undermine healthcare collaboration? Prognostic scans: Moving beyond diagnostics to predicting effectiveness of treatment First Previous 213 214 215 216 217 Next Last
